TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

TradingKeyWed, May 13

Hims & Hers (HIMS) Q1 2026 Earnings Preview: GLP-1 Pivot, Subscriber Surge & Stock Catalyst Watch

TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

TradingKeyTue, May 12

Hantavirus Appears Sporadically, Is Now the Opportunity to Buy Vaccine Concept Stock Moderna?

TradingKey - As of May 7, the World Health Organization (WHO) has confirmed eight cases of hantavirus infection associated with the cruise ship, including three deaths. The Andes strain of the virus is the only hantavirus subtype known to be capable of limited person-to-person transmission.

TradingKeySun, May 10

Blue Cross Blue Shield Pays $2.67 Billion Settlement, Why ELV Stock Price Wasn’t Dragged Down?

TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

TradingKeyThu, May 7

Is Novo Nordisk Positioned for Recovery in 2026 Amid Rising Competition and AI Innovations?

TradingKey - Since 1923, Novo Nordisk (NVO) has thrived as a pharmaceutical company based in Denmark, primarily focusing on two business areas: Obesity and diabetes, and Rare Diseases.

TradingKeyMon, May 4

KeyAI

